Trulicity 1.5 MG/0.5 ML pen 0.5ML

Ended Awarded

Contract number
SPE2DR26F9F15
Awardee
Awarding agency
Obligated
$14,919

Award facts

Contract value 100% obligated
$14,919.46 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Conshohocken, PA 19428, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency awarded a delivery order valued at $14,919.46 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens (0.5 mL), a prescription diabetes medication. The contract was awarded on November 13, 2025, with an ultimate completion date of November 14, 2025, and utilizes firm fixed-price pricing with no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.

AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, has established itself as a critical vendor for federal medical procurement, particularly for the Defense Logistics Agency's medical supply chain. The company's extensive portfolio of federal contract awards demonstrates its capability to supply a broad range of pharmaceutical products and medical supplies to support military and veteran healthcare systems. All reviewed contract awards, including this delivery order, were competitively awarded, reflecting the company's ability to meet stringent federal procurement requirements. The DLA Troop Support is planning to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning AmerisourceBergen to continue serving military healthcare systems alongside the Defense Health Agency, U.S. Coast Guard, and other government entities.

Quick answers

Who was awarded contract SPE2DR26F9F15?

SPE2DR26F9F15 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 13, 2025.

How much is contract SPE2DR26F9F15 worth?

The government has obligated $14,919 on SPE2DR26F9F15.

Is contract SPE2DR26F9F15 an order under another contract?

Yes. SPE2DR26F9F15 is a delivery order under SPE2DR25D3103, an indefinite delivery contract.

Was contract SPE2DR26F9F15 competed?

The extent of competition for SPE2DR26F9F15 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award